Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics

Active, not recruiting

• Conditions: Anxiety Disorders
• Interventions: Other: Psychosocial treatment

• Registration Number: NCT02218996
• Lead Sponsor: Helse Stavanger HF

Brief Summary

The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-08
• Study First Submitted: 2014-08-08
• Study First Submitted QC: 2014-08-14
• Study First Posted: 2014-08-18
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-17
• Last Update Posted: 2024-12-18
• Primary Completion: 2028-12-31
• Study Completion: 2029-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 260

Inclusion Criteria

• Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman & Albano, 1996).
• The anxiety disorder is the patients primary diagnosis.
• Informed concent is given.

Exclusion Criteria

• The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Psychosocial treatment	Psychosocial treatment	Children and adolescents with anxiety disorders

Primary Outcome Measures

Name	Time	Method
The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).	The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.	Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders.

Secondary Outcome Measures

Name	Time	Method
Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
Spence Children's Anxiety Scale (SCAS; Spence, 1998)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995).	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)
The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999).	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)
Clinical Global Impressions (CGI; Guy, 1976).	The outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

Trial Locations

Locations (1)

BUPA Helse Stavanger; 🇳🇴 Stavanger, Rogaland, Norway